CDDRX | RMEBX | CDDRX / RMEBX | |
Total Expense Ratio | 0.58 | 1.07 | 54% |
Annual Report Gross Expense Ratio | 0.58 | 1.07 | 54% |
Fund Existence | 13 years | 11 years | - |
Gain YTD | 12.648 | 13.105 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 45.1B | 111B | 41% |
Annual Yield % from dividends | 1.63 | 1.09 | 149% |
Returns for 1 year | 7.35 | 6.26 | 117% |
Returns for 3 years | 47.95 | 41.49 | 116% |
Returns for 5 years | 74.60 | 62.00 | 120% |
Returns for 10 years | 143.85 | 101.70 | 141% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GNOM | 37.87 | 0.52 | +1.40% |
Global X Genomics & Biotechnology ETF | |||
JXI | 77.11 | 0.99 | +1.31% |
iShares Global Utilities ETF | |||
BNDX | 49.39 | 0.04 | +0.08% |
Vanguard Total International Bond ETF | |||
LCDS | 61.73 | N/A | N/A |
JPMorgan Fundamental Data Sci Lg Cor ETF | |||
CHY | 11.14 | -0.05 | -0.45% |
Calamos Convertible and High Income Fund |